Abstract
Low density lipoproteins (LDL) have considerable potential as carriers for site-specific drug delivery.1 The core of native LDL is composed mainly of cholesteryl esters of long chain unsaturated fatty acids, which can be removed and replaced with other hydrophobic compounds. These core compounds can be regarded as specific combinations of structural units that not only provide efficient packing in the core environment, but also enhance passage through the phospholipid coat into the core. For example, it has been demonstrated that esters of unsaturated fatty acids are incorporated into heptane-extracted LDL far more effectively than esters of the corresponding saturated fatty acids.2 The aim of the present study, which is an extension of the pioneering work of Kahl et a1,3–7 is to find which combination of these structural elements forms the best drug anchor for delivery of o-carborane to a tumour in reconstituted LDL.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
P. C. de Smidt & Th. J. C. van Berkel, LDL-Mediated drug targeting, Critical Reviews in Therapeutic Drug Carrier Systems, 7: 99–120, 1990.
M. Krieger, M. J. McPhaul, J. L. Goldstein, M. S. Brown, Replacement of neutral lipids of low density lipoprotein with esters of long chain unsaturated fatty acids, J. Biol. Chem., 254: 3845–3853, 1979.
Stephen B. Kahl, Tumor-specific targeting of third generation boron compounds: recent experience with porphyrins, low density lipoproteins and amino acids, in: “Boron Compounds suitable for NCT for the treatment of Cancer”, National Cancer Institute, Bethesda, MD, 1988.
S. B. Kahl, J. C. Callaway, New tumor localizers: advances in the use of low density lipoproteins (LDL), StrahlentherOnkol., 165: 137–139, 1989.
S. B. Kahl, D. Pate, B. H. Laster, E. A. Popenoe, R. G. Fairchild, In vitro biological efficacy of boronated low density lipoproteins for NCT, in: “Progress in Neutron Capture Therapy for Cancer”, Ed. B. J. Allen, D.E. Moore and B.V. Harrington, Plenum Press, New York, 1992, pp 365–368.
S.B. Kahl and D. W. Pate, Low density lipoprotein reconstitutions with alkyl and aryl carboranes, in: “Advances in Neutron Capture Therapy”, Ed. A.H. Soloway, R.F. Barth and D.E. Carpenter, Plenum Press, New York, 1993, pp 399–402.
S. Kahl, Reconstitution of low density lipoproteins with carborane compounds, in: INEL BNCT Research Program Annual Report 1992, Idaho National Engineering Laboratory, Idaho Falls, Idaho, 1993, pp 5–11.
R. J. Deckelbaum, G. G. Shipley, D. M. Small, Structure and interactions of lipids in human plasma low density lipoproteins, J. Biol. Chem., 252: 744–754, 1977.
R. N. Grimes, “Carboranes”, Academic Press, New York, 1970.
M. M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochern., 72: 248–254, 1976.
Y. Setiawan, M. D. Smith, D.E. Moore, B. J. Allen, Pharmacokinetics and neutron capture therapy of melanoma xenografts using boronated low density lipoprotein. (these proceedings)
Y. Setiawan, T. Rise, D. E. Moore, Fourier transform infrared (FTIR) spectrometry for the assay of polyhedral boron compounds in plasma and pharmaceutical formulations, Pharm. Res., 11: 723–727, 1994.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Smith, M.D., Setiawan, Y., Moore, D.E. (1996). Optimization of Drug Anchor for Ortho-Carborane in Reconstitution of Low Density Lipoproteins for Neutron Capture Therapy. In: Mishima, Y. (eds) Cancer Neutron Capture Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9567-7_19
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9567-7_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9569-1
Online ISBN: 978-1-4757-9567-7
eBook Packages: Springer Book Archive